ArticleAsia Pacific allergy2025

Successful switch to tezepelumab for severe asthma and chronic rhinosinusitis with nasal polyps.

Yoshiro Kai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.